Why do most clinical trials fail?
Because we’re only seeing part of the picture.
Traditional proteomics breaks proteins into fragments. That’s like trying to understand a sentence by reading one word at a time—out of order.
At ImmPro, we analyze whole proteoforms—the complete, functional versions of proteins—to reveal insights that fragmented data simply can’t deliver.
Introducing, ProteoSight™
The first commercial platform for single-particle, top-down proteomics.
ProteoSight™ is a precision platform built to directly detect and differentiate intact proteoforms—delivering unmatched clarity for drug development, diagnostics, and clinical research.
High-Mass Proteoform Resolution
Direct Single-Particle Measurements
Compatible with Challenging Samples